Back
SpringWorks Therapeutics Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46
SWTX
SpringWorks Therapeutics
Last Price:
$46.22
Seasonality Move:
3.79%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
SpringWorks Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 41.28 | Buy |
| 20-day SMA: | 40.04 | Buy |
| 50-day SMA: | 47.44 | Sell |
| 200-day SMA: | 39.3 | Buy |
| 8-day EMA: | 42.38 | Buy |
| 20-day EMA: | 41.85 | Buy |
| 50-day EMA: | 43.42 | Buy |
| 200-day EMA: | 40.95 | Buy |
SpringWorks Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 58.88 | Buy |
| Chaikin Money Flow: | 57018164 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.08 - 45.94) | Buy |
| Bollinger Bands (100): | (35.82 - 50.36) | Buy |
SpringWorks Therapeutics Technical Analysis
| Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for SpringWorks Therapeutics Stock
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 46.18 while SWTX 8-day simple moving average is 41.28, which is a Buy signal.
-
The stock price of SWTX is 46.18 while SpringWorks Therapeutics 20-day SMA is 40.04, which makes it a Buy.
-
SpringWorks Therapeutics 50-day simple moving average is 47.44 while SWTX share price is 46.18, making it a Sell technically.
-
SWTX stock price is 46.18 and SpringWorks Therapeutics 200-day simple moving average is 39.30, creating a Buy signal.
SWTX Technical Analysis vs Fundamental Analysis
Sell
46
SpringWorks Therapeutics (SWTX)
is a Sell
Is SpringWorks Therapeutics a Buy or a Sell?
-
SpringWorks Therapeutics stock is rated a SellThe current SpringWorks Therapeutics [SWTX] share price is $46.18. The Score for SWTX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
SpringWorks Therapeutics Stock Info
Market Cap:
3.5B
Price in USD:
46.18
Share Volume:
79.8M
SpringWorks Therapeutics 52-Week Range
52-Week High:
62.00
52-Week Low:
28.21
Sell
46
SpringWorks Therapeutics (SWTX)
is a Sell
SpringWorks Therapeutics Share Price Forecast
-
What is the SpringWorks Therapeutics stock price today?The SpringWorks Therapeutics stock price is 46.18 USD today.
-
Will SWTX stock go up or go down?SpringWorks Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is SpringWorks Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, SpringWorks Therapeutics is overvalued.
Is SpringWorks Therapeutics Stock a Buy?
-
SpringWorks Therapeutics share price is 46.18 while SWTX 8-day exponential moving average is 42.38, which is a Buy signal.
-
The stock price of SWTX is 46.18 while SpringWorks Therapeutics 20-day EMA is 41.85, which makes it a Buy.
-
SpringWorks Therapeutics 50-day exponential moving average is 43.42 while SWTX share price is 46.18, making it a Buy technically.
-
SWTX stock price is 46.18 and SpringWorks Therapeutics 200-day simple moving average is 40.95, creating a Buy signal.
Fundamental Analysis of SpringWorks Therapeutics
Is SpringWorks Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.52 per share, and an increase next year of $2.29 per share.
Technical Analysis of SpringWorks Therapeutics
Should I short SpringWorks Therapeutics stock?
-
SWTX Moving Average Covergence Divergence (MACD) indicator is -0.68, suggesting SpringWorks Therapeutics is a Sell
-
SpringWorks Therapeutics Relative Strength Index (RSI) is 58.88, which suggest SpringWorks Therapeutics is overbought
-
The Bollinger Bands (25) for SpringWorks Therapeutics is (37.08 - 45.94), which suggest SpringWorks Therapeutics is a Buy
-
The Bollinger Bands (100) for SpringWorks Therapeutics is (35.82 - 50.36), which suggest SpringWorks Therapeutics is a Buy
* SpringWorks Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.